| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
10 Apr 2023
This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR...
-
27 Mar 2023
Kisqali plus endocrine therapy (ET) significantly reduced the risk of disease recurrence compared to standard ET alone in the adjuvant setting1 NATALEE is the first and only positive Phase III...
-
15 Mar 2023
This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR...
10 Mar 2023This is a test from PR Newswire. This is a test from PR Newswire. "This is a test from PR Newswire." This is a test from PR Newswire. 'This is a test from PR Newswire. This is a test from PR...
17 Feb 2023Selected participants will receive a $50,000 grant and leadership development training to further propel positive impact in their communities PURCHASE, N.Y., Feb. 22, 2023 /PRNewswire/ -- The...